000963:SSEHuadong Medicine Co., Ltd Analysis

Huadong Medicine is trading at CNY 27.84, barely above its technical support of CNY 27.80 and well below its 20‑day SMA of 30.30, indicating a bearish price environment. The 14‑day RSI sits at 18, signaling oversold conditions, while the MACD remains in a bearish configuration and volume trends downward, suggesting limited buying pressure. Volatility is elevated at roughly 24% over the past 30 days, yet the stock’s beta is exceptionally low (≈0.11), implying limited market‑wide risk exposure.
Fundamentally, the company trades at a forward P/E of 11.1 versus an industry average of 27.2, and its DCF‑derived fair value of ~CNY 22.9 suggests a modest discount to current levels. With a dividend yield of 3.3% and a payout ratio under 50%, cash flow generation is solid, debt is low (debt‑to‑equity ~8%), and ROE stands near 14%, supporting the case for sustainable shareholder returns. Analyst price targets cluster around CNY 45‑47, implying upside potential if the stock can break through its current resistance near CNY 34.